This review aims to summarize the importance of the mammalian nicotinamide adenine dinucleotide (NAD)-dependent deacetylase SIRT1 as a critical mediator that coordinates metabolic responses to caloric restriction and the recent progress in the development of SIRT1-targeted caloric restriction mimetics. It also discusses possible trade-offs between robustness and frailty in caloric restriction and the applicability of caloric restriction or SIRT1-targeted caloric restriction mimetics to humans.
Introduction
The Japanese have long carried an old wisdom for longevity through their dietary culture. Although their lifestyle and diet have rapidly been westernized in the last century, a concept of 'hara hachi bunme' or 'hara hachi bu', eating until you are 80% full, has been a traditional dietary control to achieve good health and longevity among the Japanese. Indeed, Ekiken Kaibara (1630-1714), a great philosopher and scientist who enjoyed unusual longevity in the Edo era, has already described this concept in his 'Yoˆjoˆ-kun (The Book of Life-nourishing Principles)' in 1713. More than 200 years later, Clive M. McCay and his colleagues provided an experimental proof for this concept, demonstrating the life spanextending effect of caloric restriction, a dietary regimen low in calories without malnutrition, using rats [1] . Since this discovery, it has been established that caloric restriction retards aging and extends life span in a wide variety of organisms, including yeast [2,3 ], worms [4 ,5] , flies [6, 7] , rodents [8, 9 ] , and possibly primates [10 ,11 ] .
Caloric restriction also delays the onset and slows the progression of many age-related diseases, such as cancer, kidney disease, autoimmune disease, atherosclerosis, and diabetes [11 ,12] . Although a number of hypotheses have been proposed to explain the antiaging and life spanextending effects of caloric restriction [1], recent evidence suggests that caloric restriction activates a highly regulated metabolic program that translates nutritional cues to alterations in transcription, thereby mediating the physiological response to caloric restriction [13, 14] .
For the past decade, the evolutionarily conserved Sir2 (silent information regulator 2) family of nicotinamide adenine dinucleotide (NAD)-dependent deacetylases/ ADP-ribosyltransferases, also called 'sirtuins,' has drawn much attention in the field of aging research as a critical regulator that mediates a variety of physiological responses to caloric restriction [15] . Furthermore, small chemical compounds that can activate sirtuins, particularly the mammalian Sir2 ortholog SIRT1, have raised a broad interest in ' caloric restriction mimetics', providing a hope to mimic beneficial effects of caloric restriction without suffering from a practical difficulty in attempting caloric restriction [16,17 ,18] . Despite these exciting findings, several important questions still remain. Does increased dosage/activity of SIRT1 indeed mimic the physiological response to caloric restriction? Does SIRT1 activation always promote robustness at a systemic level? Could SIRT1 activation be effective to achieve good health and longevity in real human life? This short review will focus specifically on the importance of SIRT1, summarizing its function as a critical mediator that coordinates metabolic responses to caloric restriction, and will discuss potential pros and cons in the idea of activating SIRT1 as a functional mimicry of caloric restriction in mammals.
SIRT1, a key mediator that orchestrates the physiological response to caloric restriction
In experimental model organisms, such as yeast, worms, and flies, it has been demonstrated that Sir2 family proteins play a critical role in the regulation of aging and longevity [15, 19] . Increasing the dosage or activity of Sir2 and its orthologs extends the life spans of those organisms, whereas deletions or mutations of the Sir2 genes shorten their life spans [20] [21] [22] [23] [24] [25] . In certain genetic backgrounds, Sir2 family proteins are also required for the caloric restriction-mediated life span extension in those organisms [23, [26] [27] [28] [29] . In mammals, there are seven sirtuin family members, named SIRT1 through SIRT7, and the majority of mammalian sirtuin research has so far focused on the function of SIRT1 [15, 30, 31 ] . Although it is still unclear whether SIRT1 regulates aging and longevity in mammals, numerous studies have demonstrated that SIRT1 regulates critical metabolic responses to nutritional cues, particularly to low nutritional input, in multiple tissues, as well as cell survival in response to stress and damage, both features common to the response to caloric restriction in mammals [15, 30, 31 ] . Because many review articles have already addressed the metabolic functions of SIRT1, I will focus on the connection between SIRT1 and caloric restriction in this section.
Three loss-of-function mouse studies have so far provided genetic evidence that connects SIRT1 to caloric restriction in mice ( Fig. 1) [32 , 33, 34] . Chen et al. [33] have examined physical activity during caloric restriction in wild type and SIRT1-deficient mice. Whereas wildtype caloric restriction mice show a significant increase in physical activity compared with ad libitum-fed controls, SIRT1-deficient mice do not exhibit such an increase. This is not due to a reduced capacity for movement because SIRT1-deficient mice perform as well as or better than wild-type mice in rotarod and treadmill tests, suggesting that SIRT1 plays a critical role in mediating the caloric restriction-induced increase in physical activity. Nisoli et al. [34] have shown that the caloric restriction-induced enhancement of mitochondrial biogenesis is blunted in endothelial nitric oxide synthase (eNOS)-deficient mice. Interestingly, they have found that nitric oxide upregulates SIRT1 expression, which is also blunted in eNOS-deficient mice. Therefore, it has been proposed that caloric restriction induces eNOS and nitric oxide, thereby upregulating SIRT1 and mitochondrial biogenesis. The caloric restriction-induced mitochondrial biogenesis might be explained by the ability of SIRT1 to deacetylate and activate peroxisome proliferator-activated receptor-g coactivator 1a (PGC-1a), a key transcriptional regulator of glucose production and mitochondrial function [35] . Consistent with these findings, Boily et al. [32 ] have recently provided evidence that SIRT1-deficient mice are metabolically inefficient and unable to adapt to caloric restriction normally.
Three gain-of-function mouse studies have also provided supportive evidence (Fig. 2) [36 ,37 ,38 ] . Bordone et al. [37 ] have generated SIRT1-overexpressing transgenic (SIRT1-KI) mice in which the SIRT1 cDNA is knocked into the ubiquitously expressed b-actin locus. In SIRT1-KI mice, SIRT1 is moderately overexpressed in SIRT1 and caloric restriction Imai 351
Figure 1 Genetic linkage between caloric restriction and SIRT1
Caloric restriction enhances mitochondrial biogenesis by upregulating the expression of the endothelial nitric oxide synthase (eNOS), promoting the production of nitric oxide, and increasing SIRT1 expression (left). The activation of PGC-1a by SIRT1 likely mediates the effect of caloric restriction on mitochondria. Caloric restriction also enhances physical activity likely by increasing NAD content (right) and upregulating SIRT1 protein levels (middle) in the brain. SIRT1 is also required for the metabolic adaptation to caloric restriction, although the underlying mechanism is unknown. CR, caloric restriction; eNOS, endothelial nitric oxide synthase; NAD, nicotinamide adenine dinucleotide; NO, nitric oxide. several tissues including white and brown adipose tissues and brain, but not in liver and muscle, without affecting b-actin protein levels. The SIRT1-KI mice display phenotypes that mimic some of the physiological changes in response to caloric restriction, including decreased blood insulin and glucose levels, improved glucose tolerance, reduced fat mass and circulating free fatty acid and leptin levels, reduced total blood cholesterol levels, enhanced oxygen consumption, improved activity in rotarod tests, and delayed reproductive timing. Certain caloric restriction-mediated physiological changes, including those in blood levels of triglycerides, HDL cholesterol, insulinlike growth factor 1, adiponectin, and corticosterone, are not recapitulated in SIRT1-KI mice, and whether their life span is extended is not known. Nonetheless, this study currently provides the best evidence for the significance of SIRT1 in the induction of physiological responses to caloric restriction. Pfluger et al. [38 ] and Banks et al. [36 ] have generated SIRT1-overexpressing transgenic mice using large genomic fragments that contain the entire Sirt1 gene locus. Although results from these two groups are not entirely consistent, both SIRT1 transgenic mice show significant protection from the adverse effects of high-fat diet (HFD) on glucose metabolism, which caloric restriction has also been reported to convey. Interestingly, Banks et al. [36 ] have also found that their SIRT1 transgenic (SirBACO) mice have the increased production of adiponectin likely through the deacetylation of FOXO1 by SIRT1. This particular phenotype might provide a potential explanation for the increase in hepatic insulin sensitivity observed in Sir-BACO mice. On the other hand, Pfluger et al. [38 ] have found that whereas their SIRT1 transgenic mice are protected from HFD-induced hepatic inflammation, they show serious hypersensitivity to lipopolysaccharide (LPS) and die much earlier than wild-type mice in response to LPS [38 ] . These phenotypes are likely due to the SIRT1-mediated suppression of NF-kB activation in the liver.
These findings collectively support the notion that SIRT1 is a key player that mediates the physiological response to caloric restriction. In particular, increasing SIRT1 dosage is effective to provide significant protection from HFD-induced metabolic complications, indicating that SIRT1 activation likely promotes robustness in the regulation of metabolism. Given that increased SIRT1 dosage causes hypersensitivity to LPS, however, systemic SIRT1 activation might also generate frailty in response to unexpected environmental stimuli, such as bacterial infection. Effective trade-offs between robustness and frailty have been suggested in a highly optimized tolerance (HOT) architecture underlying complex biological networks, such as metabolism [39] [40] [41] . Therefore, it will be of great importance to carefully assess the effects of SIRT1 activation on the trade-offs between robustness and frailty at a systemic level.
Sirtuin activating compounds: do they mimic physiological effects of caloric restriction?
Provided that SIRT1 plays a key role in mediating metabolically beneficial effects of caloric restriction, the idea of developing chemical compounds that activate SIRT1 has naturally attracted researchers in the field of sirtuin biology. Sinclair's group [14] has reported that a group of polyphenolic compounds (STACs), such as resveratrol, fisetin, and butein, can activate the catalytic activity of Sir2 and its orthologs and extend the life spans of yeast, worms, and flies [21, 25] . Furthermore, they have reported that in HFD-fed mice, resveratrol (22.4 mg/kg/day) conveys increased insulin sensitivity, improved motor function, improved hepatic pathology, enhanced mitochondrial biogenesis, increased AMP-activated protein kinase (AMPK) and PGC-1a activity, and increased survival [42] . Lagouge et al. [43] have also reported that resveratrol (400 mg/kg/day) prevents HFD-induced obesity, increases the aerobic capacity of the skeletal muscle, enhances endurance in running, and improves insulin sensitivity. These effects are associated with an induction of genes required for oxidative phosphorylation and mitochondrial biogenesis likely caused by the deacetylation and activation of PGC-1a by activated SIRT1. More recently, Pearson et al. [44 ] have shown that resveratrol (100, 400, and 2400 mg/kg of food) induces gene expression profiles similar to those induced by every-other-day feeding, which is known to convey physiological effects similar to those in caloric restriction, particularly in liver and skeletal muscle. Resveratrol treatment also slows down age-associated transcriptional changes in liver and skeletal muscle and delays functional decline in old mice. Nonetheless, resveratrol fails to increase the life span of standard diet-fed mice, whereas it does increase the life span of HFD-fed mice. These results support the idea that resveratrol can be used as a potential caloric restriction mimetic possibly through the activation of SIRT1 in mammals.
However, whereas resveratrol is often baldly referred to as a SIRT1 activator, it is still not clear to what extent the pharmacological effects of resveratrol depend on SIRT1. For example, Dasgupta and Milbrandt [45] have reported that resveratrol activates AMPK and thereby mitochondrial biogenesis in a LKB1 kinase-dependent but SIRT1independent manner. Resveratrol has also been known as an antioxidant [46] . Therefore, it is very likely that resveratrol has a number of 'off-target' effects as a plant-derived 'xenohormetic' compound [47] . This pleiotropic feature of resveratrol may not necessarily be bad as far as this compound can mimic the beneficial effects of caloric restriction and overall promote systemic robustness. Nonetheless, to overcome this specificity problem of resveratrol, more potent and specific STACs have been developed. Milne et al. [48] have reported new SIRT1-activating nonpolyphenolic compounds that are 1000-fold more potent than resveratrol. They have also shown that these new STACs improve glucose homeostasis and insulin sensitivity in diet-induced and genetically obese rodent models, implicating a novel therapeutic intervention for the treatment of type 2 diabetes. Most recently, Feige et al. [49 ] have further examined the pharmacological effects of SRT1720, one of those new STACs, on glucose and cholesterol homeostasis, endurance and locomoter functions, hepatic oxidative functions, and energy expenditure in HFD-fed mice. Although SRT1720 does not have the direct action on AMPK, this compound can improve conditions in the aforementioned functions at the doses of 100-500 mg/kg/day in HFD-fed mice. Interestingly, SRT1720 induces the expression of genes required for fatty acid oxidation likely through the deacetylation of PGC-1a, FOXO1, and p53 and indirect AMPK activation, which is different from the effects of resveratrol. Given that nutritionally deprived conditions trigger a metabolic switch towards lipid oxidation, this compound appears to activate metabolic pathways that can also be activated by low nutritional cues, such as caloric restriction.
These findings suggest that resveratrol and new STACs might function as potential caloric restriction mimetics, at least in part, through the activation of SIRT1 in vivo (Fig. 2) . These drugs might also be effective to treat ageassociated metabolic complications, such as type 2 diabetes, especially when individuals suffer from dietinduced obesity. Then, the real question is what tradeoffs resveratrol and other STACs convey in terms of the balance between robustness and frailty in our system. More generally, what are the overall effects of caloric restriction on the balance between robustness and frailty at a systemic level? I will discuss this issue in the following section.
Possible trade-offs between robustness and frailty in caloric restriction
The theory of highly optimized tolerance (HOT) architecture indicates that systems that have evolved to comprise a greater scale of complexity are optimized for specific perturbations but are also inevitably susceptible to unexpected perturbations [39, 50] . Such trade-offs are an inherent, unavoidable feature of complex systems, and biological systems are not an exception. Our metabolic control system is highly robust in response to short-term and long-term alterations in food availability, and caloric restriction apparently activates multiple metabolic regulatory pathways and keeps the entire system robust even under a low nutritional condition (Fig. 3) . For example, calorically restricted mice usually maintain significantly lower blood insulin levels due to increased insulin sen-SIRT1 and caloric restriction Imai 353
Figure 3 Possible trade-offs between robustness in metabolism and frailty in infection in caloric restriction
Trade-offs between robustness and frailty are an inherent, unavoidable feature of complex systems, such as biological systems. Although caloric restriction promotes metabolic robustness, it appears to increase frailty to infectious pathogens. Given that sirtuin (SIRT1 in particular) activating compounds (STACs) function as potential caloric restriction mimetics, STACs might also convey similar trade-offs. Therefore, it will be critical to seek an optimal balance between robustness in metabolism and frailty in infection in our complex physiological system. CR, caloric restriction. sitivity but show remarkably increased postprandial insulin levels compared to ad libitum-fed mice [ [51] , our unpublished findings], indicating that the insulin-secreting function of pancreatic b cells is significantly enhanced in calorically restricted mice. Interestingly, this is exactly the phenotype of pancreatic b cell-specific SIRT1overexpressing (BESTO) mice [52] , providing another line of indirect but supportive evidence that SIRT1 mediates the enhancement of metabolic robustness in caloric restriction. Although caloric restriction promotes metabolic robustness, it has also been reported that calorically restricted animals show reduced natural killer cell function and increased mortality in response to influenza virus infection (Fig. 3) [53,54 ,55] . This potentially critical trade-off between robustness in metabolism and frailty in infection might have been unrecognized because laboratory animals are usually maintained in a specific pathogen free (SPF) environment. Furthermore, as discussed in the previous section, SIRT1 transgenic mice show serious hypersensitivity and early death in response to LPS [38 ] , implying that SIRT1 might be involved in this specific trade-off under caloric restriction (Fig. 3) . Therefore, it will be of great importance to examine whether SIRT1 activation indeed increases frailty to infectious pathogens, such as viruses and bacteria.
Then, a critical question is whether caloric restriction or SIRT1-targeted caloric restriction mimetics could be effective to achieve good health and longevity for humans. The answer to this question will not be available for a while. However, I would like to provide interesting food for thought. Multiple independent studies have so far reported that all-cause mortality and BMI show the Ushape association in men and women, namely that while there is a significant increase in all-cause mortality among people with a BMI of higher than approximately 25, people with a BMI of lower than approximately 20 also show increased mortality even after adjusting possible confounding factors [56-58,59 ,60 ] . One explanation for this phenomenon is that the low BMI group includes people who have undiagnosed preexisting disease conditions that actually cause low BMI and higher mortality [57, 58, 59 ] . This explanation might be supported by the finding that people who have chronic obstructive pulmonary diseases (COPDs) are indeed included in this group [58] . However, another potential explanation is that people with lower BMI might have higher frailty to infectious diseases due to the trade-off between robustness in metabolism and frailty in infection. Indeed, it has been reported that major causes of death in this low BMI group include tuberculosis and pneumonia [58] . If this is the case, an optimal balance between increasing metabolic robustness and decreasing frailty in infection might be achieved in a metabolic condition that can maintain BMI values associated with lowest all-cause mortality. Therefore, for people who have high BMI values associ-ated with high mortality, caloric restriction or SIRT1targeted caloric restriction mimetics would probably be effective to maximize metabolic robustness and to minimize frailty to infectious pathogens. However, we should carefully examine whether the same intervention could also achieve similar total benefits even for people who maintain a healthy or lower range of BMI.
Conclusion
In the past decade, significant progress has been made in understanding the molecular mechanism for the antiaging effects of caloric restriction in mammals. In the past couple of years, in particular, major advances have been made to understand the physiological roles of SIRT1 and other sirtuins in the regulation of metabolic responses to nutritional alterations, such as fasting and caloric restriction. On the basis of these recent findings, SIRT1 and possibly other sirtuins play a critical role in mediating beneficial physiological effects of caloric restriction. SIRT1-targeted caloric restriction mimetics are currently providing hope to achieve good health and longevity even for humans. However, in order to achieve an optimal balance between robustness and frailty in our complex physiological system, further investigation will be absolutely necessary to understand the principles of systemic robustness and its spatial and temporal dynamics in the regulation of aging and longevity in mammals. Thus, until we become ready to intervene in the complex regulatory system for aging and longevity in humans, Ekiken Kaibara's concept of 'hara hachi bunme' might be the best approach to enjoy our daily lives.
